First Time Loading...

Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229

Watchlist Manager
Zhejiang Ausun Pharmaceutical Co Ltd Logo
Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229
Watchlist
Price: 11.66 CNY -1.19% Market Closed
Updated: May 14, 2024

Wall Street
Price Targets

Price Targets Summary
Zhejiang Ausun Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang Ausun Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang Ausun Pharmaceutical Co Ltd is 20.8 CNY with a low forecast of 20.6 CNY and a high forecast of 21.41 CNY.

Lowest
Price Target
20.6 CNY
77% Upside
Average
Price Target
20.8 CNY
78% Upside
Highest
Price Target
21.41 CNY
84% Upside
Zhejiang Ausun Pharmaceutical Co Ltd Competitors:
Price Targets
000952
Hubei Guangji Pharmaceutical Co Ltd
518% Upside
6622
Zhaoke Ophthalmology Ltd
392% Upside
512
Grand Pharmaceutical Group Ltd
53% Upside
503
Lansen Pharmaceutical Holdings Ltd
78% Downside
CLN
Celon Pharma SA
8% Downside
603998
Hunan Fangsheng Pharmaceutical Co Ltd
15% Downside
002728
Teyi Pharmaceutical Group Co Ltd
46% Upside
GLENMARK
Glenmark Pharmaceuticals Ltd
9% Downside

Revenue
Forecast

Revenue Estimate
Zhejiang Ausun Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 27%.

16%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Zhejiang Ausun Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's operating income is 18%. The projected CAGR for the next 3 years is 35%.

18%
Past Growth
35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Zhejiang Ausun Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 31%.

21%
Past Growth
31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Ausun Pharmaceutical Co Ltd's stock price target?
Price Target
20.8 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang Ausun Pharmaceutical Co Ltd is 20.8 CNY with a low forecast of 20.6 CNY and a high forecast of 21.41 CNY.

What is Zhejiang Ausun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
27%

For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 27%.

What is Zhejiang Ausun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
35%

For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's operating income is 18%. The projected CAGR for the next 3 years is 35%.

What is Zhejiang Ausun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
31%

For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 31%.